The exome is just 1–2% of your genome — yet it contains 85% of all known disease-causing mutations. Whole Exome Sequencing (WES) sequences all ~21,000 protein-coding genes at 150–180X depth using Illumina iScan technology, identifying the genetic cause of complex, rare, and undiagnosed conditions that have resisted every other test. For families who have been searching for answers for years, WES is often the final, definitive answer.
Identify disease-causing variants for rare, complex, and undiagnosed genetic conditions that other tests missed
Genetic basis of autism, global developmental delay, intellectual disability, and epilepsy
Both single nucleotide variants and copy number variations identified in a single comprehensive test
Distinguish between new spontaneous mutations and inherited variants — critical for recurrence risk counseling
Specific gene variants inform targeted therapies, personalized treatment plans, and preventive strategies
Understand hereditary patterns and recurrence risks for siblings and future children
Speak with our Genomic Expert before ordering to confirm WES is the right test for your clinical situation, and understand what to expect from results.
Confirm you have a doctor's referral. Your home collection kit ships within 24 hours — EDTA blood tube and saliva swab included.
Collect both samples at home using the kit. 3–4ml EDTA blood + saliva swab. Return with prepaid courier label provided.
Exonic regions are captured and sequenced at 150–180X depth on Illumina iScan in our NABL & CAP accredited lab. All ~21,000 protein-coding genes analyzed.
Variants classified as Pathogenic, Likely Pathogenic, VUS, or Benign per ACMG and ClinVar guidelines. Primary, incidental, and carrier findings all reported.
Comprehensive WES report in 31 days. Detailed post-result consultation with our Genomic Expert to review findings and coordinate specialist referral.
A snapshot of your comprehensive WES clinical report
Complement or upgrade your genomic analysis
CMA detects chromosomal deletions and duplications that WES may miss. Often ordered together for the most comprehensive chromosomal + gene analysis.
When WES is inconclusive, WGS sequences all 3 billion base pairs including non-coding regions — the most comprehensive genetic test available.
If WES reveals or suspects BRCA variants, targeted BRCA full gene sequencing provides detailed confirmation with clinical classification per ACMG guidelines.